GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Aptus Pharma Ltd
Aptus Pharma Board Meeting on Oct 20, 2026 to Approve Results
BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 15 Oct 2026, 11:29 PM IST  ·  BSE ID: 2903d28a-ab9d-46dd-94d0-de67e7c86faa
View Original BSE Filing (PDF)
💡
In Simple Terms
Aptus Pharma's directors will meet soon to finalize and release its latest financial report for the first half of the fiscal year.
🤖 AI Summary
  • Aptus Pharma board meeting scheduled for October 20, 2026.
  • Purpose: Consider and approve unaudited financial results for H1 FY27.
  • Limited review report for the half-year ended September 30, 2026, to be taken on record.
  • Trading window for company securities remains closed until 48 hours post-results announcement.
🏢 How This Affects the Company
💰
Financial Impact
The upcoming announcement of unaudited financial results will provide an update on the company's financial performance for the half-year ended September 30, 2026.
⚠️
Risk Impact
The closure of the trading window is a standard regulatory measure to prevent insider trading ahead of financial results disclosure.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Investors should await the financial results announcement.
👤
Who Is Affected
All shareholders are affected by the upcoming disclosure of financial performance. The trading window closure affects those wishing to trade securities.
🔍
Management Signal
Management is adhering to regulatory timelines for financial reporting and insider trading prevention measures.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting outcome on October 20, 2026.
Disclosure of H1 FY27 unaudited financial results.
Reopening of the company's trading window.
LOW RISK This is a routine regulatory filing for a scheduled board meeting and trading window closure.
💡 Investor Takeaway
Aptus Pharma Ltd will announce its unaudited financial results for the half-year ended September 30, 2026, during a board meeting scheduled for October 20, 2026.
❓ Frequently Asked Questions
When is the Aptus Pharma Ltd board meeting scheduled?
The board meeting of Aptus Pharma Ltd is scheduled for Tuesday, October 20, 2026.
What will be discussed at the Aptus Pharma Ltd board meeting?
The board meeting will discuss and approve the unaudited financial results for the half-year ended September 30, 2026, and the limited review report.
When does the trading window close for Aptus Pharma Ltd?
The trading window for Aptus Pharma Ltd securities has been closed from October 1, 2026, and will remain closed until 48 hours after the financial results are declared.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.